• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以患者为中心的良性前列腺梗阻患者下尿路症状医学治疗护理:改善患者护理的关键要点——一项系统综述

Patient centred care for the medical treatment of lower urinary tract symptoms in patients with benign prostatic obstruction: a key point to improve patients' care - a systematic review.

作者信息

De Nunzio Cosimo, Presicce Fabrizio, Lombardo Riccardo, Trucchi Alberto, Bellangino Mariangela, Tubaro Andrea, Moja Egidio

机构信息

Department of Urology, Ospedale Sant'Andrea, "Sapienza" University of Rome, Rome, Italy.

Unit of Clinical Psychology, Department of Health Sciences, University of Milan, San Paolo Hospital, Milan, Italy.

出版信息

BMC Urol. 2018 Jun 26;18(1):62. doi: 10.1186/s12894-018-0376-x.

DOI:10.1186/s12894-018-0376-x
PMID:29940928
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6019782/
Abstract

BACKGROUND

Even though evidence based medicine, guidelines and algorithms still represent the pillars of the management of chronic diseases (i.e: hypertension, diabetes mellitus), a patient centred approach has been recently proposed as a successful strategy, in particular to improve drug adherence. Aim of the present review is to evaluate the unmet needs in LUTS/BPH management and the possible impact of a patient centered approach in this setting.

METHODS

A National Center for Biotechnology Information (NCBI) PubMed search for relevant articles published from January 2000 until December 2016 was performed by combining the following MESH terms: patients centred medicine, patient centered care, person centered care, patient centered outcomes, value based care, shared decision making, male, Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia, treatment. We followed the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA). All studies reporting on patient centred approach, shared decision making and evidence-based medicine were included in the review. All original article, reviews, letters, congress abstracts, and editorials comments were included in the review. Studies reporting single case reports, experimental studies on animal models and studies not in English were not included in the review.

RESULTS

Overall 751 abstracts were reviewed, out of them 87 full texts were analysed resulting in 36 papers included. The evidence summarised in this systematic review confirmed how a patient centred visit may improve patient's adherence to medication. Although a patient centred model has been rarely used in urology, management of Low Urinary Tract Symptoms (LUTS) and Benign Prostatic Obstruction (BPO) may represent the perfect ground to experiment and improve this approach. Notwithstanding all the innovations in LUTS/BPO medical treatment, the real life picture is far from ideal.

CONCLUSIONS

Recent evidence shows a dramatical low drug adherence and satisfaction to medical treatment in LUTS/BPH patients. A patient centred approach may improve drug adherence and some unmet needs in this area, potentially reducing complications and costs. However further well designed studies are needed to confirm this data.

摘要

背景

尽管循证医学、指南和算法仍是慢性病(如高血压、糖尿病)管理的支柱,但最近有人提出以患者为中心的方法是一种成功策略,特别是在提高药物依从性方面。本综述的目的是评估下尿路症状/良性前列腺增生(LUTS/BPH)管理中未满足的需求以及这种以患者为中心的方法在该领域可能产生的影响。

方法

通过组合以下医学主题词(MESH),在国家生物技术信息中心(NCBI)的PubMed数据库中检索2000年1月至2016年12月发表的相关文章:以患者为中心的医学、以患者为中心的护理、以人为本的护理、以患者为中心的结果、基于价值的护理、共同决策、男性、下尿路症状、良性前列腺增生、治疗。我们遵循系统评价和Meta分析的首选报告项目(PRISMA)。所有报告以患者为中心的方法、共同决策和循证医学的研究均纳入本综述。所有原创文章、综述、信函、会议摘要和编辑评论均纳入本综述。报告单病例报告、动物模型实验研究以及非英文研究不纳入本综述。

结果

共检索到751篇摘要,其中87篇全文进行了分析,最终纳入36篇论文。本系统评价总结的证据证实,以患者为中心的就诊可能会提高患者的药物依从性。尽管以患者为中心的模式在泌尿外科很少使用,但下尿路症状(LUTS)和良性前列腺梗阻(BPO)的管理可能是试验和改进这种方法的理想领域。尽管LUTS/BPO医学治疗有诸多创新,但实际情况远非理想。

结论

最近的证据表明,LUTS/BPH患者的药物依从性和对医疗治疗的满意度极低。以患者为中心的方法可能会提高药物依从性,并满足该领域一些未满足的需求,有可能减少并发症和成本。然而,需要进一步设计良好的研究来证实这些数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a5c/6019782/3f4cdf742ad7/12894_2018_376_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a5c/6019782/1ad9ac31b593/12894_2018_376_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a5c/6019782/3f4cdf742ad7/12894_2018_376_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a5c/6019782/1ad9ac31b593/12894_2018_376_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a5c/6019782/3f4cdf742ad7/12894_2018_376_Fig2_HTML.jpg

相似文献

1
Patient centred care for the medical treatment of lower urinary tract symptoms in patients with benign prostatic obstruction: a key point to improve patients' care - a systematic review.以患者为中心的良性前列腺梗阻患者下尿路症状医学治疗护理:改善患者护理的关键要点——一项系统综述
BMC Urol. 2018 Jun 26;18(1):62. doi: 10.1186/s12894-018-0376-x.
2
Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.经尿道前列腺动脉栓塞术治疗良性前列腺增生症男性下尿路症状。
Cochrane Database Syst Rev. 2022 Mar 29;3(3):CD012867. doi: 10.1002/14651858.CD012867.pub3.
3
Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis.男性良性前列腺增生症下尿路症状的微创治疗:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Jul 15;7(7):CD013656. doi: 10.1002/14651858.CD013656.pub2.
4
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
5
Effects of consumers and health providers working in partnership on health services planning, delivery and evaluation.消费者和医疗服务提供者合作对卫生服务规划、提供和评估的影响。
Cochrane Database Syst Rev. 2021 Sep 15;9(9):CD013373. doi: 10.1002/14651858.CD013373.pub2.
6
Interventions for promoting habitual exercise in people living with and beyond cancer.促进癌症患者及康复者进行习惯性锻炼的干预措施。
Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3.
7
Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review.COVID-19 是否是良性前列腺增生进展和其相关症状恶化的危险因素?:系统评价。
Prostate Cancer Prostatic Dis. 2022 Mar;25(1):27-38. doi: 10.1038/s41391-021-00388-3. Epub 2021 May 18.
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
9
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
10
Clinical Implications for the Early Treatment of Benign Prostatic Enlargement (BPE): a Systematic Review.良性前列腺增生(BPE)早期治疗的临床意义:一项系统评价
Curr Urol Rep. 2018 Jul 9;19(9):70. doi: 10.1007/s11934-018-0823-y.

引用本文的文献

1
Positive Psychology Insights on the Effects of Spirituality on Shared Decision-Making in Patients with Chronic Heart Failure: The Chain-Mediated Effects of Benefit-Finding and Decision Self-Efficacy.积极心理学视角下灵性对慢性心力衰竭患者共同决策的影响:获益发现与决策自我效能的链式中介效应
Healthcare (Basel). 2025 May 19;13(10):1188. doi: 10.3390/healthcare13101188.
2
MISTs for benign prostatic hyperplasia as first line interventional treatment: Alea iacta est?用于良性前列腺增生的微波热疗作为一线介入治疗:木已成舟?
Prostate Cancer Prostatic Dis. 2025 May 21. doi: 10.1038/s41391-025-00986-5.
3
A real-world evidence study of interhospital variability in the surgical treatment of patients with benign prostatic hyperplasia: the REVALURO study.

本文引用的文献

1
From evidence-based medicine to evidence-balanced medicine for individualized and personalized care: As applied to benign prostatic hyperplasia/male lower urinary tract symptoms.从循证医学到证据平衡医学以实现个体化和个性化医疗:应用于良性前列腺增生/男性下尿路症状
Int J Urol. 2017 Feb;24(2):94-95. doi: 10.1111/iju.13285.
2
Combination therapies for improved management of lower urinary tract symptoms/benign prostatic hyperplasia.用于改善下尿路症状/良性前列腺增生管理的联合疗法。
Drugs Today (Barc). 2016 Sep;52(9):501-517. doi: 10.1358/dot.2016.52.9.2525739.
3
Patient's adherence on pharmacological therapy for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) is different: is combination therapy better than monotherapy?
良性前列腺增生患者外科治疗医院间差异的真实世界证据研究:REVALURO研究
Int Urol Nephrol. 2025 Mar;57(3):775-784. doi: 10.1007/s11255-024-04239-7. Epub 2024 Oct 29.
4
Development and validation of a clinical nomogram to predict prostatic inflammation in men with lower urinary tract symptoms.预测下尿路症状男性前列腺炎症的临床列线图的开发与验证
Prostate Cancer Prostatic Dis. 2025 Jun;28(2):405-410. doi: 10.1038/s41391-024-00857-5. Epub 2024 Jul 6.
5
In-depth Microbiological Characterization of Urine From Subjects With Type 2 Diabetes.2型糖尿病患者尿液的深度微生物学特征分析
J Clin Endocrinol Metab. 2024 Dec 18;110(1):185-194. doi: 10.1210/clinem/dgae389.
6
When you say "Prostate", don't forget to say "Bladder"!当你提到“前列腺”时,别忘了提及“膀胱”!
Prostate Cancer Prostatic Dis. 2024 Mar;27(1):5-6. doi: 10.1038/s41391-023-00747-2. Epub 2023 Oct 23.
7
Role of Perilesional Sampling of Patients Undergoing Fusion Prostate Biopsies.融合前列腺活检患者病变周围取样的作用
Life (Basel). 2023 Aug 10;13(8):1719. doi: 10.3390/life13081719.
8
Patients' Preferences and Expectations in Overactive Bladder: A Systematic Review.膀胱过度活动症患者的偏好与期望:一项系统评价
J Clin Med. 2023 Jan 4;12(2):396. doi: 10.3390/jcm12020396.
9
Real-world data and treatment patterns of patients with lower urinary tract symptoms due to benign prostatic hyperplasia in Germany: an observational study using health insurance claims data.德国良性前列腺增生症导致下尿路症状患者的真实世界数据和治疗模式:使用健康保险索赔数据的观察性研究。
World J Urol. 2021 Dec;39(12):4381-4388. doi: 10.1007/s00345-021-03787-2. Epub 2021 Jul 22.
10
Laparoscopic simple prostatectomy vs bipolar plasma enucleation of the prostate in large benign prostatic hyperplasia: a two-center 3-year comparison.腹腔镜单纯前列腺切除术与双极等离子前列腺剜除术治疗大体积良性前列腺增生的 3 年双中心比较。
World J Urol. 2021 Jul;39(7):2613-2619. doi: 10.1007/s00345-020-03512-5. Epub 2020 Nov 11.
患者对良性前列腺增生(BPH)相关下尿路症状(LUTS)药物治疗的依从性各不相同:联合治疗比单一疗法更好吗?
BMC Urol. 2015 Sep 21;15:96. doi: 10.1186/s12894-015-0090-x.
4
Urgency and other lower urinary tract symptoms in men aged ≥ 40 years: a Belgian epidemiological survey using the ICIQ-MLUTS questionnaire.40岁及以上男性的尿急及其他下尿路症状:一项使用ICIQ-MLUTS问卷的比利时流行病学调查。
Int J Clin Pract. 2015 Mar;69(3):358-65. doi: 10.1111/ijcp.12541. Epub 2015 Feb 4.
5
EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction.EAU 指南:非神经原性男性下尿路症状包括良性前列腺增生的评估。
Eur Urol. 2015 Jun;67(6):1099-1109. doi: 10.1016/j.eururo.2014.12.038. Epub 2015 Jan 19.
6
Drug adherence and clinical outcomes for patients under pharmacological therapy for lower urinary tract symptoms related to benign prostatic hyperplasia: population-based cohort study.药物治疗对良性前列腺增生相关下尿路症状患者的药物依从性和临床结局:基于人群的队列研究。
Eur Urol. 2015 Sep;68(3):418-25. doi: 10.1016/j.eururo.2014.11.006. Epub 2014 Nov 20.
7
The connection between evidence-based medicine and shared decision making.循证医学与共同决策之间的联系。
JAMA. 2014 Oct 1;312(13):1295-6. doi: 10.1001/jama.2014.10186.
8
Interventions for improving the adoption of shared decision making by healthcare professionals.提高医疗保健专业人员采用共同决策的干预措施。
Cochrane Database Syst Rev. 2014 Sep 15(9):CD006732. doi: 10.1002/14651858.CD006732.pub3.
9
Evidence based medicine: a movement in crisis?循证医学:一场危机中的运动?
BMJ. 2014 Jun 13;348:g3725. doi: 10.1136/bmj.g3725.
10
What is the most bothersome lower urinary tract symptom? Individual- and population-level perspectives for both men and women.最困扰人的下尿路症状是什么?男性和女性个体及群体层面的观点。
Eur Urol. 2014 Jun;65(6):1211-7. doi: 10.1016/j.eururo.2014.01.019. Epub 2014 Jan 24.